Tag Biogen

New Treatments, News

EC has authorized SKYCLARYS® for the treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older

Biogen announced the European Commission (EC) has authorized SKYCLARYS® (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older. 👉 SKYCLARYS is the first treatment approved within the European Union for this rare,…

February 12, 2024

Company News, News, Statements

Biogen announced the appointment of Monish Patolawala to the Company’s Board of Directors.

Biogen today announced the appointment of Monish Patolawala, currently President and CFO of 3M, to the Company’s Board of Directors, effective January 1, 2024. As an accomplished financial executive, Mr. Patolawala is qualified as an Audit Committee financial expert and…

November 6, 2023